BioTek Readers Receive BellBrook Transcreener® Certifications

BioTek’s complete line of multi-mode microplate readers have now earned Transcreener HTS Assay certifications from BellBrook Labs. Performance of BioTek readers including the Synergy™ Neo2 and Cytation™ 5 have been confirmed as meeting validation requirements across BellBrook’s supported Fluorescence Intensity, Fluorescence Polarization and TR-FRET detection modes.

Synergy Neo2 is designed for speed and ultra-high performance, incorporating BioTek’s patented Hybrid Technology™, with its independent optical paths that ensure uncompromised performance in all detection modes. Continuously variable bandwidth quadruple monochromators, sensitive high transmission filter-based optics, and up to 4 PMTs provide ultra-fast measurements with excellent results.

Cytation 5 is a modular, upgradable multi-mode reader that combines automated digital microscopy and conventional microplate detection. Cytation 5 also incorporates BioTek’s patented Hybrid Technology with both filter- and monochromator-based detection; the microscopy module provides up to 60x magnification in fluorescence, brightfield, color brightfield and phase contrast. Available laser autofocus and image-based autofocus ensures fast and accurate image acquisition with minimized phototoxicity across a broad application range.

Other BioTek readers earning the Transcreener certifications include Synergy™ H1, Synergy™ 2, and Synergy™ HTX.

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. These technologies are used to aid life science research, facilitate drug discovery, provide rapid and cost-effective analysis, and enable sensitive, accurate quantification of molecules across diverse applications. BioTek espouses a “Think Possible” approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations. The company is frequently honored for local accomplishments and technological innovations, including Best Places to Work in Vermont, Frost & Sullivan North American New Product Innovation Award for Workflow Solutions in Life Sciences, SelectScience’s Drug Discovery Product of the Year–Scientists' Choice Award, and a Silver Edison Award for the Cytation Cell Imaging Multi-Mode Reader.

Transcreener is a registered trademark of BellBrook Labs Corporation, USA.

September 9, 2015